---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-002873"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:32:36.342187+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Psychemedics reports Q1 2024 revenue down 9% to $5.4M; net loss widens to $0.7M

## Summary
- Revenue $5.4M vs $5.9M in Q1 2023, a 9% decline.
- Net loss $0.7M ($0.12 per share) vs loss of $0.4M ($0.07) in prior year.
- CEO cites revenue decrease but remains optimistic; focusing on client acquisition and new market applications.

## SEC filing metadata
- accession: 0001171843-24-002873
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184324002873/0001171843-24-002873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184324002873/f8k_051424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-002873
- JSON: https://secwatch.observer/filing/0001171843-24-002873.json
- Plain text: https://secwatch.observer/filing/0001171843-24-002873.txt

## Key facts
- Earnings Releases
  PSYCHEMEDICS CORP reported the first quarter ended March 31, 2024 results: revenue $5.4 million, net income $0.7 million, EPS $0.12 per share.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $5.4 million
  - Net income: $0.7 million
  - EPS: $0.12 per share
  - Result: reported results
  source text: The Company’s revenue for the quarter ended March 31, 2024, was $5.4 million versus $5.9 million for the quarter ended March 31, 2023, a decrease of 9%. Net loss for the quarter was $0.7 million, or $0.12 per share, compared to a net loss of $0.4 million, or $.07 per share, for the comparable quarter last year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/806517/000117184324002873/0001171843-24-002873-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.